Barrie Nelson

Barrie Nelson is the President of Nurocor. They specialize in digitalized clinical development, clinical innovation, and digital data flow. They have held several senior roles in clinical data management and standards, including Executive Vice President, Clinical Innovation and Chief Standards Officer at Nurocor from 2022 to 2025, and prior roles at Onyx Pharmaceuticals (Senior Director and Head of Clinical Data Management, 2014–2015) and Amgen (Director Biomedical Data Stewardship; Statistical Programming Senior Manager; Senior Clinical Programmer Analyst, 2010–2014); as well as roles at GSK (1999–2000) and CDISC (2016–2017). They studied at Nottingham Trent University from 1983 to 1986.